Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patients.

Objective: To evaluate the safety profile and efficacy of salvage regimens containing amprenavir (APV) 600 mg twice daily and ritonavir (RTV) 200 mg twice daily.

Design: Prospective, single-center study.

Method: The patient database of the department of infectious diseases was screened for patients who had failed at least two successive three-drug combinations.